Ten recommendations to improve use of medicines in developing countries

Health Policy and Planning

Volumn 16, Issue 1, 2001, Pages 13-20

  Laing, R O ^a   Hogerzeil, H V ^b   Ross Degnan, D ^c  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEVELOPING COUNTRY; DRUG MISUSE; DRUG MONITORING; DRUG USE; HEALTH CARE MANAGEMENT; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; STAFF TRAINING; STANDARDIZATION;

EID: 0035114899     PISSN: 02681080     EISSN: None     Source Type: Journal    
DOI: 10.1093/heapol/16.1.13     Document Type: Review

References (74)

1. Rational drug use: An unsolved problem
2. International network for the rational use of drugs (INRUD)
3. Intervention research to promote clinically effective and economically efficient use of pharmaceuticals: The International Network for Rational Use of Drugs
4. International conference on national medicinal policies - The way forward
5. Improving pharmaceutical use in primary care in developing countries: A critical review of experience and lack of experience
6. Do national drug policies improve drug use? A review of experiences in developing countries
7. Improving the use of pharmaceuticals through patient and community level interventions
8. Impact of economic factors on use of medicines: Concepts and evidence on selected issues
9. Basing prescription drug payment on economic analysis: The case of Australia
10. Implications of the Australian guidelines for the United States
11. Managing the pharmacy benefit in Medicare HMOs: What do we really know?
12. A national survey of the arrangements managed-care plans make with physicians
13. General practitioner fund-holding and prescribing expenditure control. Evidence from a rural English health authority
14. General practitioner fundholding: Weighing the evidence
15. Lessons from international experience in controlling pharmaceutical expenditure. Influencing doctors
16. The pharmacist's duty under OBRA-90 standards
17. Computer-based drug-utilization review - Risk, benefit, or boondoggle?
18. Clinical guidelines in Scotland: A SIGN of the times
19. Field tests for rational drug use in twelve developing countries
20. From research to action: The Gunungkidul experience
21. Effect of clinical guidelines on medical practice: A systematic review of rigorous evaluations
22. Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelines
23. Developing standard treatment guidelines in Malawi
24. Closing the gap between research and practice: An overview of systematic reviews of interventions to promote the implementation of research findings
25. Kenya: Updating the Essential Drugs List
26. The use of essential drugs
27. The value and effects of implementing an essential drugs list in the Lagos University Teaching Hospital
28. Rational use of cytotoxic drugs in a developing country
29. Drug and Therapeutic Committees in Australia: Expected and actual performance
30. Enforcing a policy for restricting antimicrobial drug use
31. Antibiotic formulary selection
32. Impact of a short course in pharmacotherapy for undergraduate medical students
33. Revision of undergraduate pharmacy curricula
34. The essential drugs programme in Zimbabwe: New approaches to training
35. Changing physician performance. A systematic review of the effect of continuing medical education strategies
36. Impact of formal continuing medical Education. Do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?
37. Small group intervention vs formal seminar for improving appropriate drug use
38. Improving primary health care through systematic supervision: A controlled field trial
39. Improving drug use through continuing education: A randomized controlled trial in Zambia
40. Effect of training on the clinical management of malaria by medical assistants in Ghana
41. The impact of face to face educational outreach on diarrhea treatment in pharmacies
42. Group problem solving
43. Implementing clinical practice guidelines: Social influence strategies and practitioner behavior change
44. Interactional group discussion: Results of a controlled trial using a behavioral intervention to reduce the use of injections in public health facilities
45. Changing physician prescribing patterns: Evaluation of an educational strategy for acute diarrhea in Mexico City
46. From research to public health interventions. I. Impact of an educational strategy for physicians to improve treatment practices of common diseases
47. Self-learning for self medication: An alternative to improve the rational use of OTCs
48. Intervention test of training and supervision on prescribing and dispensing practices
49. The effects of an intervention on the drug selling behavior of sarisari (variety) store keepers in some villages in the Philippines
50. How effective is the surveillance in ensuring the appropriate distribution of, and patient's accessibility to drugs: The case for steroid tablets
51. Pharmaceutical management at the central and local levels
52. The effects of different charging mechanisms on rational drug use in Eastern rural Nepal
53. Decentralization of health services in Western Highlands Province, Papua New Guinea: An attempt to administer health service at the subdistrict level